Search Results
You are looking at 1 - 3 of 3 items for
- Author: Patrice Mollard x
- Refine by access: All content x
Search for other papers by Pauline Campos in
Google Scholar
PubMed
EPSRC Centre for Predictive Modelling in Healthcare, University of Exeter, Exeter, UK
Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK
Search for other papers by Jamie J Walker in
Google Scholar
PubMed
Search for other papers by Patrice Mollard in
Google Scholar
PubMed
In most species, survival relies on the hypothalamic control of endocrine axes that regulate critical functions such as reproduction, growth, and metabolism. For decades, the complexity and inaccessibility of the hypothalamic–pituitary axis has prevented researchers from elucidating the relationship between the activity of endocrine hypothalamic neurons and pituitary hormone secretion. Indeed, the study of central control of endocrine function has been largely dominated by ‘traditional’ techniques that consist of studying in vitro or ex vivo isolated cell types without taking into account the complexity of regulatory mechanisms at the level of the brain, pituitary and periphery. Nowadays, by exploiting modern neuronal transfection and imaging techniques, it is possible to study hypothalamic neuron activity in situ, in real time, and in conscious animals. Deep-brain imaging of calcium activity can be performed through gradient-index lenses that are chronically implanted and offer a ‘window into the brain’ to image multiple neurons at single-cell resolution. With this review, we aim to highlight deep-brain imaging techniques that enable the study of neuroendocrine neurons in awake animals whilst maintaining the integrity of regulatory loops between the brain, pituitary and peripheral glands. Furthermore, to assist researchers in setting up these techniques, we discuss the equipment required and include a practical step-by-step guide to performing these deep-brain imaging studies.
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Norbert Chauvet in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Taoufik El-Yandouzi in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Marie-Noëlle Mathieu in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Audrey Schlernitzauer in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Evelyne Galibert in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Chrystel Lafont in
Google Scholar
PubMed
Search for other papers by Paul Le Tissier in
Google Scholar
PubMed
Search for other papers by Iain C Robinson in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Patrice Mollard in
Google Scholar
PubMed
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Département d'Endocrinologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universités Montpellier I and II, Division of Molecular Neuroendocrinology, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France
Search for other papers by Nathalie Coutry in
Google Scholar
PubMed
Our view of anterior pituitary organization has been altered with the recognition that folliculo-stellate (FS) and somatotroph cell populations form large-scale three-dimensional homotypic networks. This morphological cellular organization may optimize communication within the pituitary gland promoting coordinated pulsatile secretion adapted to physiological needs. The aim of this study was to identify the molecules involved in the formation and potential functional organization and/or signaling within these cell–cell networks. Here, we have focused on one class of cell adhesion molecules, the cadherins, since β-catenin has been detected in the GH cell network. We have characterized, by qPCR and immunohistochemistry, their cellular expression and distribution. We have also examined whether their expression could be modulated during pituitary tissue remodeling. The mouse anterior pituitary has a restricted and cell-type specific repertoire of cadherin expression: cadherin-11 is exclusively expressed in TSH cells; N-cadherin displays a ubiquitous expression pattern but with different levels of expression between endocrine cell types; E-cadherin is restricted to homotypic contacts between FS cells; while cadherin-18 is expressed both in somatotrophs and FS cells. Thus, each cell type presents a defined combinatorial expression of different subsets of cadherins. This cell-type specific cadherin expression profile emerges early during development and undergoes major changes during postnatal development. These results suggest the existence within the anterior pituitary of cell–cell contact signaling based on a defined pattern of cadherin expression, which may play a crucial role in cellular recognition during the formation and fate of pituitary cell homotypic networks.
Search for other papers by Thomas M Braxton in
Google Scholar
PubMed
Search for other papers by Dionne E A Sarpong in
Google Scholar
PubMed
Search for other papers by Janine L Dovey in
Google Scholar
PubMed
Search for other papers by Anne Guillou in
Google Scholar
PubMed
Search for other papers by Bronwen A J Evans in
Google Scholar
PubMed
Search for other papers by Juan M Castellano in
Google Scholar
PubMed
Search for other papers by Bethany E Keenan in
Google Scholar
PubMed
Search for other papers by Saja Baraghithy in
Google Scholar
PubMed
Search for other papers by Sam L Evans in
Google Scholar
PubMed
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain
Search for other papers by Manuel Tena-Sempere in
Google Scholar
PubMed
Search for other papers by Patrice Mollard in
Google Scholar
PubMed
Search for other papers by Joseph Tam in
Google Scholar
PubMed
Search for other papers by Timothy Wells in
Google Scholar
PubMed
Human Prader–Willi syndrome (PWS) is characterised by impairments of multiple systems including the growth hormone (GH) axis and skeletal growth. To address our lack of knowledge of the influence of PWS on skeletal integrity in mice, we have characterised the endocrine and skeletal phenotype of the PWS-IC del mouse model for ‘full’ PWS and determined the impact of thermoneutrality. Tibial length, epiphyseal plate width and marrow adiposity were reduced by 6, 18 and 79% in male PWS-IC del mice, with osteoclast density being unaffected. Similar reductions in femoral length accompanied a 32% reduction in mid-diaphyseal cortical diameter. Distal femoral Tb.N was reduced by 62%, with individual trabeculae being less plate-like and the lattice being more fragmented (Tb.Pf increased by 63%). Cortical strength (ultimate moment) was reduced by 26% as a result of reductions in calcified tissue strength and the geometric contribution. GH and prolactin contents in PWS-IC del pituitaries were reduced in proportion to their smaller pituitary size, with circulating IGF-1 concentration reduced by 37–47%. Conversely, while pituitary luteinising hormone content was halved, circulating gonadotropin concentrations were unaffected. Although longitudinal growth, marrow adiposity and femoral geometry were unaffected by thermoneutrality, strengthened calcified tissue reversed the weakened cortex of PWS-IC del femora. While underactivity of the GH axis may be due to loss of Snord116 expression and impaired limb bone geometry and strength due to loss of Magel2 expression, comprehensive analysis of skeletal integrity in the single gene deletion models is required. Our data imply that thermoneutrality may ameliorate the elevated fracture risk associated with PWS.